BRPI0520482A2 - amidas do ácido 4-amino-tieno [3,2-c] piridina-7-carboxìlico - Google Patents

amidas do ácido 4-amino-tieno [3,2-c] piridina-7-carboxìlico

Info

Publication number
BRPI0520482A2
BRPI0520482A2 BRPI0520482-8A BRPI0520482A BRPI0520482A2 BR PI0520482 A2 BRPI0520482 A2 BR PI0520482A2 BR PI0520482 A BRPI0520482 A BR PI0520482A BR PI0520482 A2 BRPI0520482 A2 BR PI0520482A2
Authority
BR
Brazil
Prior art keywords
pyridine
amino
carboxylic acid
compounds
acid amides
Prior art date
Application number
BRPI0520482-8A
Other languages
English (en)
Inventor
Kin-Chun Luk
Lee Apostle Mcdermott
Pamela Loreen Rossman
Peter Michael Wovkulich
Zhuming Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0520482A2 publication Critical patent/BRPI0520482A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

AMIDAS DO áCIDO 4-AMINO-TIENO[3,2-c]PIRIDINA-7-CARBOXìLICO. A presente invenção refere-se a novas amidas do ácido 4-amino-tieno[3,2-c]piridina-7-carboxílico de fórmula 1, e seus sais e ésteres farmaceuticamente aceitáveis compostos de fórmula 1 que são inibidores seletivos das cinases KDR e/ou FGFR. Estes compostos e seus sais farmaceuticamente aceitáveis são agentes antiproliferativos úteis no tratamento ou no controle de tumores sólidos, em particular tumores sólidos de mama, cólon, pulmão e próstata. Também são descritas composições farmacêuticas ou medicamentos contendo esses compostos, processos para fazer os mesmos e métodos de tratamento de câncer usando esses compostos.
BRPI0520482-8A 2005-08-16 2005-08-16 amidas do ácido 4-amino-tieno [3,2-c] piridina-7-carboxìlico BRPI0520482A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/054022 WO2007019884A1 (en) 2005-08-16 2005-08-16 Novel 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides

Publications (1)

Publication Number Publication Date
BRPI0520482A2 true BRPI0520482A2 (pt) 2009-05-12

Family

ID=35159670

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520482-8A BRPI0520482A2 (pt) 2005-08-16 2005-08-16 amidas do ácido 4-amino-tieno [3,2-c] piridina-7-carboxìlico

Country Status (9)

Country Link
EP (1) EP1917015A1 (pt)
JP (1) JP2009504692A (pt)
KR (1) KR100995790B1 (pt)
AU (1) AU2005335661A1 (pt)
BR (1) BRPI0520482A2 (pt)
CA (1) CA2619459A1 (pt)
IL (1) IL189181A0 (pt)
MX (1) MX2008002060A (pt)
WO (1) WO2007019884A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1926737B1 (en) * 2005-09-15 2017-03-15 F. Hoffmann-La Roche AG 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
AR070317A1 (es) * 2008-02-06 2010-03-31 Osi Pharm Inc Furo (3,2-c) piridina y tieno (3,2-c) piridinas
US20120189641A1 (en) 2009-02-25 2012-07-26 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
US8642834B2 (en) 2009-02-27 2014-02-04 OSI Pharmaceuticals, LLC Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2010099138A2 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
US9896730B2 (en) 2011-04-25 2018-02-20 OSI Pharmaceuticals, LLC Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment
WO2013152252A1 (en) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Combination anti-cancer therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232320B1 (en) * 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
CA2502429A1 (en) * 2002-10-31 2004-05-21 Amgen Inc. Antiinflammation agents
JP2006528685A (ja) * 2003-05-06 2006-12-21 スミスクライン ビーチャム コーポレーション 新規化合物
US20050020619A1 (en) * 2003-07-24 2005-01-27 Patrick Betschmann Thienopyridine kinase inhibitors
US20050026944A1 (en) * 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors

Also Published As

Publication number Publication date
CA2619459A1 (en) 2007-02-22
IL189181A0 (en) 2008-06-05
AU2005335661A1 (en) 2007-02-22
EP1917015A1 (en) 2008-05-07
WO2007019884A1 (en) 2007-02-22
KR20080027945A (ko) 2008-03-28
MX2008002060A (es) 2008-04-16
KR100995790B1 (ko) 2010-11-22
JP2009504692A (ja) 2009-02-05

Similar Documents

Publication Publication Date Title
BRPI0409366A (pt) compostos de pirimido
BR0317480A (pt) Derivados de piridino[2,3-d]pirimidina como inibidores kdr e fgfr seletivos
ES2856880T3 (es) Inhibidores tricíclicos condensados de KRAS y métodos de uso de los mismos
BR0206496A (pt) Diaminotiazóis
BRPI0520482A2 (pt) amidas do ácido 4-amino-tieno [3,2-c] piridina-7-carboxìlico
EA201000552A1 (ru) Производные пирроло[2,3-d]пиримидина в качестве ингибиторов протеинкиназы в
UY27937A1 (es) Compuestos pirimido que tienen actividad antiproliferativa
PH12018500957A1 (en) Imidazo[4,5-c] quinolin -2-one compounds and their use in treating cancer
EA201691151A1 (ru) Соединения для лечения пациентов с ros1-мутантными раковыми клетками
BR0315912A (pt) Compostos pirimìdicos com atividade antiproliferativa (ii)
EA201890650A1 (ru) ПРОИЗВОДНЫЕ 8-[6-[3-(АМИНО)ПРОПОКСИ]-3-ПИРИДИЛ]-1-ИЗОПРОПИЛ-ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНА В КАЧЕСТВЕ СЕЛЕКТИВНЫХ МОДУЛЯТОРОВ КИНАЗЫ МУТАЦИИ АТАКСИИ-ТЕЛЕАНГИЭКТАЗИИ (ATM) ДЛЯ ЛЕЧЕНИЯ РАКА
JO2787B1 (en) Alternative amide derivatives and methods of use
ATE557015T1 (de) 3,4-diarylpyrazole als proteinkinaseinhibitoren
UA86614C2 (ru) Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата
MY167135A (en) Fused heterocyclic derivatives and methods of use
SV2010003491A (es) 2- anilinopurin-8-onas como inhibidores de ttk/mps1 para el tratamiento de trastornos proliferativos
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
EA200900388A1 (ru) Бензоксазолы и оксазолопиридины, применимые в качестве ингибиторов киназ janus
MX2010007523A (es) Nuevos derivados de pirazolo[3,4-d]pirimidina como farmacos anticancer.
BRPI0518231A2 (pt) derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica
BRPI0516052A (pt) uso de zd6474 ou de um sal farmaceuticamente aceitável do mesmo e de imatinib, composição farmacêutica, kit, e, método para a produção de um efeito antiangiogênico e/ou de redução da permeabilidade vascular em um animal de sangue quente
BRPI0410913A (pt) benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
CY1111547T1 (el) Συνδυασμος zd6474 και πεμετρεξεδης
BR112014011805A2 (pt) morfolinilbenzotriazinas para uso em terapia de câncer
DE602006020919D1 (de) Kombination aus azd2171 und pemetrexed

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 7A ANUIDADE.